New therapy aims to ease grief and PTSD for families of ICU patients

NCT ID NCT05587517

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a short therapy program called EMPOWER for family members who make decisions for critically ill patients in the ICU. The therapy includes breathing exercises, mindfulness, and coping techniques delivered by a mental health professional. Researchers will compare it to supportive conversation to see if it reduces grief, PTSD, and depression over a year.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
EMPOWER (a behavioral therapy combining cognitive behavioral and acceptance and commitment techniques)
What this could lead to
If it works, this could provide an effective, brief therapy to help family surrogates cope with grief and trauma after a loved one's critical illness.
What could go wrong
This is a Phase 2 trial with only 172 participants, so results may not apply to everyone. The therapy is new and may not reduce symptoms more than supportive conversation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CRITICAL CARE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Memorial Sloan Kettering Cancer Center

    RECRUITING

    New York, New York, 10021, United States

  • NewYork-Presbyterian Weill Cornell Medicine

    RECRUITING

    New York, New York, 10065, United States

  • University of Miami

    NOT_YET_RECRUITING

    Miami, Florida, 33136, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.